These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stereotactic radiotherapy for adrenal oligometastases. Borghesi S; Casamassima F; Aristei C; Grandinetti A; Di Franco R Rep Pract Oncol Radiother; 2022; 27(1):52-56. PubMed ID: 35402020 [TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiotherapy for bone oligometastases. Colosimo C; Pasqualetti F; Aristei C; Borghesi S; Forte L; Mignogna M; Badii D; Bosio M; Paiar F; Nanni S; Bertocci S; Lastrucci L; Parisi S; Ingrosso G Rep Pract Oncol Radiother; 2022; 27(1):40-45. PubMed ID: 35402030 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases. Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068 [TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiotherapy for brain oligometastases. Lupattelli M; Tini P; Nardone V; Aristei C; Borghesi S; Maranzano E; Anselmo P; Ingrosso G; Deantonio L; di Monale E Bastia MB Rep Pract Oncol Radiother; 2022; 27(1):15-22. PubMed ID: 35402029 [TBL] [Abstract][Full Text] [Related]
9. Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review. Matsushita H; Jingu K; Umezawa R; Yamamoto T; Ishikawa Y; Takahashi N; Katagiri Y; Kadoya N Technol Cancer Res Treat; 2018 Jan; 17():1533033818803597. PubMed ID: 30352542 [TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning. Coon D; Gokhale AS; Burton SA; Heron DE; Ozhasoglu C; Christie N Clin Lung Cancer; 2008 Jul; 9(4):217-21. PubMed ID: 18650169 [TBL] [Abstract][Full Text] [Related]
11. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028 [TBL] [Abstract][Full Text] [Related]
13. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795 [TBL] [Abstract][Full Text] [Related]